Blood Pressure Control in Patients Aged Above and Below 75 Years

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Feb 1

PMID 38300966

Authors

Hae Hyuk Jung

Affiliations

Soon will be listed here.

Abstract

It remains unclear what the blood pressure target is and at which point in life it is appropriate for antihypertensive treatment. This study aimed to determine age-specific systolic blood pressure (SBP) targets. In a nationwide cohort of 296,470 hypertensive patients aged ≥75 years and a representative cohort of 259,028 hypertensives aged 45-74 years, multivariable-adjusted incidence rates of cardio-kidney composite events, overt dementia, and all-cause deaths were estimated across yearly-averaged on-treatment SBP levels according to age and the presence of 4 additional risk factors (diabetes, dyslipidemia, albuminuria, and smoking). For cardio-kidney events, on-treatment SBP showed positive curvilinear associations with higher risks at ≥135 mm Hg in most while an attenuated association in age ≥85 years. For overt dementia, SBP showed flat or slightly inverted associations in elderly while a small positive association in age 45-64 years. For all-cause mortality, SBP showed J-shaped associations having right-shifting tendency with age. For risk categories with ≥2, 1, and no additional risk factors, the respective mortality rate differences between SBP 145-154 mm Hg and 125-134 mm Hg were 4.6 (95% confidence interval [CI], 2.0 to 7.3), 1.2 (95% CI, -0.3 to 2.8), and 0.1 (95% CI, -1.4 to 1.8) per 1000 person-years in age ≥75 years and 2.9 (95% CI, 1.7 to 4.3), 0.7 (95% CI, 0.1 to 1.4), and 0.9 (95% CI, 0.2 to 1.6) per 1000 person-years in age 45-74 years. In conclusion, the BP target can be relaxed in very old patients and in elderly patients with few risk factors. However, strict BP control may be needed in patients with multiple risk factors even in those with advanced age.

References

Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

Williamson J, Supiano M, Applegate W, Berlowitz D, Campbell R, Chertow G . Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. JAMA. 2016; 315(24):2673-82. PMC: 4988796. DOI: 10.1001/jama.2016.7050. View

Kochanek K, Murphy S, Xu J, Arias E . Deaths: Final Data for 2017. Natl Vital Stat Rep. 2020; 68(9):1-77. View

Arguedas J, Leiva V, Wright J . Blood pressure targets in adults with hypertension. Cochrane Database Syst Rev. 2020; 12:CD004349. PMC: 8094587. DOI: 10.1002/14651858.CD004349.pub3. View

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-13. DOI: 10.1016/s0140-6736(02)11911-8. View

Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G . Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med. 2021; 385(14):1268-1279. DOI: 10.1056/NEJMoa2111437. View

Beckett N, Peters R, Fletcher A, Staessen J, Liu L, Dumitrascu D . Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358(18):1887-98. DOI: 10.1056/NEJMoa0801369. View

Musini V, Tejani A, Bassett K, Puil L, Wright J . Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database Syst Rev. 2019; 6:CD000028. PMC: 6550717. DOI: 10.1002/14651858.CD000028.pub3. View

Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah A, Denaxas S . Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014; 383(9932):1899-911. PMC: 4042017. DOI: 10.1016/S0140-6736(14)60685-1. View

10.

. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985; 291(6488):97-104. PMC: 1416260. DOI: 10.1136/bmj.291.6488.97. View

11.

Qaseem A, Wilt T, Rich R, Humphrey L, Frost J, Forciea M . Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017; 166(6):430-437. DOI: 10.7326/M16-1785. View

12.

Jung H, Park J, Jeong J . Blood Pressure-Related Risk Among Users Versus Nonusers of Antihypertensives: A Population-Based Cohort in Korea. Hypertension. 2018; 71(6):1047-1055. DOI: 10.1161/HYPERTENSIONAHA.118.11068. View

13.

Lonn E, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P . Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016; 374(21):2009-20. DOI: 10.1056/NEJMoa1600175. View

14.

Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y . Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014; 371(15):1392-406. DOI: 10.1056/NEJMoa1407963. View

15.

Jung H . Association of Optimal Blood Pressure With Critical Cardiorenal Events and Mortality in High-Risk and Low-Risk Patients Treated With Antihypertension Medications. JAMA Netw Open. 2019; 2(8):e199307. PMC: 6714012. DOI: 10.1001/jamanetworkopen.2019.9307. View

16.

Musini V, Gueyffier F, Puil L, Salzwedel D, Wright J . Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev. 2017; 8:CD008276. PMC: 6483466. DOI: 10.1002/14651858.CD008276.pub2. View

17.

Wright Jr J, Williamson J, Whelton P, Snyder J, Sink K, Rocco M . A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373(22):2103-16. PMC: 4689591. DOI: 10.1056/NEJMoa1511939. View